BRKR – Bruker Corporation
Bruker CorporationBRKR
$41.19Name : Bruker Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $6,241,603,072.00
EPSttm : 0.52
Bruker Corporation
$41.19
1.46%$0.61Float Short %
9.6
Margin Of Safety %
15
Put/Call OI Ratio
1.36
EPS Next Q Diff
0.17
EPS Last/This Y
1.7
EPS This/Next Y
0.33
Price
41.83
Target Price
53
Analyst Recom
2.21
Performance Q
-3.8
Relative Volume
2.13
Beta
1.18
Ticker: BRKR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | BRKR | 36.74 | 1.79 | 0.00 | 13305 |
| 2025-06-03 | BRKR | 37.43 | 1.79 | 0.70 | 13307 |
| 2025-06-04 | BRKR | 37.85 | 1.79 | 0.78 | 13310 |
| 2025-06-05 | BRKR | 37.72 | 1.77 | 1.57 | 13404 |
| 2025-06-06 | BRKR | 38.28 | 1.78 | 1.71 | 13414 |
| 2025-06-09 | BRKR | 39.21 | 1.78 | 1.35 | 13434 |
| 2025-06-10 | BRKR | 40.66 | 1.79 | 1.00 | 13663 |
| 2025-06-11 | BRKR | 39.75 | 1.79 | 0.82 | 13735 |
| 2025-06-12 | BRKR | 39.86 | 1.79 | 0.01 | 13734 |
| 2025-06-13 | BRKR | 38.31 | 1.79 | 0.86 | 13726 |
| 2025-06-16 | BRKR | 39.08 | 1.80 | 0.34 | 13727 |
| 2025-06-17 | BRKR | 37.58 | 1.80 | 1.36 | 13686 |
| 2025-06-18 | BRKR | 38.43 | 1.79 | 1.14 | 13707 |
| 2025-06-20 | BRKR | 38.05 | 1.80 | 0.93 | 13712 |
| 2025-06-23 | BRKR | 38.75 | 1.53 | 0.08 | 7630 |
| 2025-06-24 | BRKR | 39.66 | 1.42 | 0.96 | 7915 |
| 2025-06-25 | BRKR | 40.92 | 1.41 | 0.10 | 7936 |
| 2025-06-26 | BRKR | 42.21 | 1.30 | 1.34 | 8305 |
| 2025-06-27 | BRKR | 41.79 | 1.36 | 0.61 | 8701 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | BRKR | 36.74 | -13.5 | 314.8 | 2.46 |
| 2025-06-03 | BRKR | 37.40 | -13.5 | 321.5 | 2.46 |
| 2025-06-04 | BRKR | 37.81 | -13.5 | 318.7 | 2.46 |
| 2025-06-05 | BRKR | 37.69 | -13.5 | 312.9 | 2.46 |
| 2025-06-06 | BRKR | 38.31 | -13.6 | 320.9 | 2.46 |
| 2025-06-09 | BRKR | 39.21 | -13.6 | 323.8 | 2.46 |
| 2025-06-10 | BRKR | 40.68 | -13.6 | 329.4 | 2.46 |
| 2025-06-11 | BRKR | 39.73 | -13.6 | 305.1 | 2.46 |
| 2025-06-12 | BRKR | 39.87 | -13.6 | 315.9 | 2.46 |
| 2025-06-13 | BRKR | 38.31 | -13.6 | 298.6 | 2.46 |
| 2025-06-16 | BRKR | 39.09 | -13.6 | 322.6 | 2.46 |
| 2025-06-17 | BRKR | 37.58 | -13.6 | 299.0 | 2.46 |
| 2025-06-18 | BRKR | 38.43 | -13.6 | 322.9 | 2.46 |
| 2025-06-20 | BRKR | 38.08 | -13.6 | 310.7 | 2.46 |
| 2025-06-23 | BRKR | 38.75 | -13.6 | 321.4 | 2.46 |
| 2025-06-24 | BRKR | 39.70 | -13.6 | 324.4 | 2.46 |
| 2025-06-25 | BRKR | 40.92 | -13.6 | 327.1 | 2.46 |
| 2025-06-26 | BRKR | 42.17 | -13.2 | 326.8 | 2.46 |
| 2025-06-27 | BRKR | 41.83 | -13.2 | 311.0 | 2.46 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | BRKR | 0.04 | -0.99 | 7.49 |
| 2025-06-03 | BRKR | 0.04 | -0.99 | 7.49 |
| 2025-06-04 | BRKR | 0.04 | -0.99 | 7.49 |
| 2025-06-05 | BRKR | 0.04 | -0.99 | 7.49 |
| 2025-06-06 | BRKR | 0.04 | -0.99 | 7.49 |
| 2025-06-09 | BRKR | 0.05 | -0.93 | 7.49 |
| 2025-06-10 | BRKR | 0.05 | -0.93 | 7.49 |
| 2025-06-11 | BRKR | 0.05 | -0.93 | 9.02 |
| 2025-06-12 | BRKR | 0.05 | -0.93 | 9.02 |
| 2025-06-13 | BRKR | 0.05 | -0.93 | 9.03 |
| 2025-06-16 | BRKR | 0.05 | -1.19 | 9.03 |
| 2025-06-18 | BRKR | 0.05 | -1.19 | 9.03 |
| 2025-06-20 | BRKR | 0.05 | -1.19 | 9.03 |
| 2025-06-23 | BRKR | 0.05 | -1.19 | 9.03 |
| 2025-06-24 | BRKR | 0.05 | -1.19 | 9.03 |
| 2025-06-25 | BRKR | 0.05 | -1.19 | 9.03 |
| 2025-06-26 | BRKR | 0.05 | -1.19 | 9.60 |
| 2025-06-27 | BRKR | 0.05 | -1.19 | 9.60 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.47
Avg. EPS Est. Current Quarter
0.45
Avg. EPS Est. Next Quarter
0.64
Insider Transactions
0.05
Institutional Transactions
-1.19
Beta
1.18
Average Sales Estimate Current Quarter
811
Average Sales Estimate Next Quarter
888
Fair Value
48.09
Quality Score
62
Growth Score
88
Sentiment Score
55
Actual DrawDown %
55.9
Max Drawdown 5-Year %
-62.2
Target Price
53
P/E
79.6
Forward P/E
15.33
PEG
8.55
P/S
1.84
P/B
3.49
P/Free Cash Flow
36.28
EPS
0.53
Average EPS Est. Cur. Y
2.46
EPS Next Y. (Est.)
2.79
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
2.31
Relative Volume
2.13
Return on Equity vs Sector %
-19.5
Return on Equity vs Industry %
-14
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
311
Bruker CorporationSector: Healthcare
Industry: Medical Devices
Employees: 11396
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.
stock quote shares BRKR – Bruker Corporation Stock Price stock today
news today BRKR – Bruker Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BRKR – Bruker Corporation yahoo finance google finance
stock history BRKR – Bruker Corporation invest stock market
stock prices BRKR premarket after hours
ticker BRKR fair value insiders trading